A firm of Johnson & Johnson’s stature — and, frankly, that makes for a decidedly short list of players in the pantheon of global companies — knows all about stark business risks and attendant downsides. In J&J’s case, company-directed lawsuits are a recurrent reality, especially given Johnson & Johnson’s huge presence in the health care…
The question is simple and eminently straightforward, to wit: Should nursing home administrators in New York and across the country be able to require prospective patients to agree to mandatory arbitration to resolve disputes as a prerequisite to home admittance, thereby surrendering their right to litigate a contested matter in court before a judge and…
The so-called “Internet of things” (IoT) has been an oft-used phrase in media reports and stories over the past several years. For readers of our New York health care blog at Daniels, Porco & Lusardi, LLP, who might not know much about that concept, it quite simply refers to a device that can be connected…
Carole Faig, a regulatory expert focused on health care matters, concedes the sheer challenges and uncertainty that American medical industry actors routinely face as they seek to promote health and simultaneously prosper. It’s just a given, she says, and something that care principals — “CEOs and other leaders in the health space” — must simply…
The New York State Department of Health made headlines earlier this week when it announced that the cultivation, production and sale of medical marijuana was going to be greatly expanded moving forward with the granting of licenses to five new firms. The move, which brings the number of “registered organizations” licensed to take part in…
When we note on our health law representation website at the well-established New York law firm of Daniels, Porco & Lusardi, LLP, that our deep legal team is “prepared to resolve any type of health care dispute that may arise for a care-delivery professional or business,” that is actually saying a lot. And here’s why:…
Concededly, pity is not a word often linked with people’s perceptions of business actors operating within the health care industry. Entities like large hospital chains, pharmaceutical companies, device makers and insurers are often viewed as too-big-to-fail entities that amass incalculably high profits and are beyond the reach of any real injury inflicted by outside forces….
Stories in New York and across the country seem to surface just about every day to underscore — as we note on our health care law website at Daniels, Porco & Lusardi, LLP — that, “Within the health care arena, every legal matter comes with layers of regulatory and compliance issues that must be addressed.”…
As we have duly noted in prior select posts, many individuals and enterprises operating within the health care realm in New York and nationally are routinely under intense public and regulatory scrutiny. And among all those industry participants, there is perhaps no other entity so closely perused as the U.S. Food and Drug Administration, especially…
Doctor-owned medical facilities — chiefly hospitals — are bad for consumers and the public health. No, wait a minute, they’re a positive development that materially promotes a salutary bottom line in a truly broad-based way. Those polar-opposite views are the core bullet points in any debate focusing upon close physician involvement in an ownership capacity…